Frequency of elevated serum aluminum levels in adult dialysis patientsJAFFE, Jared A; LIFTMAN, Carol; GLICKMAN, Joel D et al.American journal of kidney diseases. 2005, Vol 46, Num 2, pp 316-319, issn 0272-6386, 4 p.Article

Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney diseaseISAKOVA, Tamara; GUTIERREZ, Orlando M; SMITH, Kelsey et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 2, pp 584-591, issn 0931-0509, 8 p.Article

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. CommentarySILVER, J; SUKI, W. N; BLAIR, A. T et al.Kidney international. 2007, Vol 72, Num 9, issn 0085-2538, 1041-1043, 1130-1137 [11 p.]Article

A bitter pill to swallowDAVID, S; MERSCHER, S; SCHMIDT-GUERTLER, H et al.Clinical nephrology. 2009, Vol 72, Num 4, pp 319-321, issn 0301-0430, 3 p.Article

The treatment of hyperphosphataemia in CKD: calcium-based or calcium-free phosphate binders?COZZOLINO, Mario; MAZZAFERRO, Sandro; BRANDENBURG, Vincent et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 2, pp 402-407, issn 0931-0509, 6 p.Article

Does the choice of phosphate binder affect trace element levels in chronic kidney disease patients treated by regular haemodialysis?VEIGHEY, Kristin; BOOTH, John; DAVENPORT, Andrew et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 3, pp 1006-1010, issn 0931-0509, 5 p.Article

Phosphate : despite advances in research, the benefits to patients remain limitedDE BROE, Marc E.Kidney international. 2009, Vol 75, Num 9, pp 880-881, issn 0085-2538, 2 p.Article

Oral phosphate binders: History and prospectsKAZAMA, Junichiro James.Bone (New York, NY). 2009, Vol 45, issn 8756-3282, S8-S12, SUP1Article

Choosing Not to Take Phosphate Binders: The Role of Dialysis Patients' Medication BeliefsWILEMAN, Vari; CHILCOT, Joseph; NORTON, Sam et al.The Nephron journals. 2011, Vol 119, Num 3, issn 1660-8151, C205-C213Article

Dissociation between progression of coronary artery calcification and endothelial function in hemodialysis patients: a prospective pilot studyKALIL, Roberto S; FLANIGAN, Michael; STANFORD, William et al.Clinical nephrology. 2012, Vol 78, Num 1, pp 1-9, issn 0301-0430, 9 p.Article

Ectopic mineralization of connective tissue in Abcc^6-/- mice : effects of dietary modifications and a phosphate binder -a preliminary studyLARUSSO, Jennifer; QIUJIE JIANG; QIAOLI LI et al.Experimental dermatology. 2008, Vol 17, Num 3, pp 203-207, issn 0906-6705, 5 p.Article

Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of lifeGARDULF, A; PALSSON, M; NICOLAY, U et al.Clinical nephrology. 2011, Vol 75, Num 4, pp 319-327, issn 0301-0430, 9 p.Article

Interprovincial differences in the achievement of K/DOQI targets of mineral metabolism in CanadaLEBNER, Adrianne C; BEARD, Kristin M; SOROKA, Steven D et al.Nephrology, dialysis, transplantation (Print). 2011, Vol 26, Num 1, pp 156-163, issn 0931-0509, 8 p.Article

Survival in end stage renal disease : calcium carbonate vs. sevelamerBORZECKI, A. M; LEE, A; WANG, S. W et al.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 6, pp 617-624, issn 0269-4727, 8 p.Article

SEVELAMER HYDROCHLORIDE IN PERITONEAL DIALYSIS PATIENTS : RESULTS OF A MULTICENTER CROSS-SECTIONAL STUDYRAMOS, Rosa; MORESO, Francesc; RAMIREZ DE ARELLANO, Manuel et al.Peritoneal dialysis international. 2007, Vol 27, Num 6, pp 697-701, issn 0896-8608, 5 p.Article

Lanthanum carbonate (Fosrenol®) : a novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patientsALBAAJ, F; HUTCHISON, A. J.International journal of clinical practice (Esher). 2005, Vol 59, Num 9, pp 1091-1096, issn 1368-5031, 6 p.Article

Diaminobutane (DAB) Dendrimers Are Potent Binders of Oral PhosphateWILLIAMS, Katie B; BARYCKA, Katarzyna; ZELLA, Julia B et al.Journal of bone and mineral research (Print). 2009, Vol 24, Num 1, pp 97-101, issn 0884-0431, 5 p.Article

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysisEVENEPOEL, Pieter; SELGAS, Rafael; CAPUTO, Flavia et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 1, pp 278-285, issn 0931-0509, 8 p.Article

Factors associated with mortality in patients new to haemodialysisSPIEGEL, David M; RAGGI, Paolo; SMITS, Gerard et al.Nephrology, dialysis, transplantation (Print). 2007, Vol 22, Num 12, pp 3568-3572, issn 0931-0509, 5 p.Article

Hyperphosphataemia and treatment with sevelamer in haemodialysis patientsCIZMAN, Borut.Nephrology, dialysis, transplantation (Print). 2003, Vol 18, pp v47-v49, issn 0931-0509, SUP5Conference Paper

Mineral metabolism management in Canadian peritoneal dialysis patientsSOROKA, S. D; BEARD, K. M; MENDELSSOHN, D. C et al.Clinical nephrology. 2011, Vol 75, Num 5, pp 410-415, issn 0301-0430, 6 p.Article

Efficacy and safety of SBR759, a new iron-based phosphate binderBLOCK, Geoffrey A; BRILLHART, Stephanie L; PERSKY, Martha S et al.Kidney international. 2010, Vol 77, Num 10, pp 897-903, issn 0085-2538, 7 p.Article

Adequate phosphate binding with lanthanum carbonate attenuates arterial calcification in chronic renal failure ratsNEVEN, Ellen; DAMS, Geert; POSTNOV, Andrei et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 6, pp 1790-1799, issn 0931-0509, 10 p.Article

The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysisJAMAL, Sophie A; FITCHETT, David; LOK, Charmaine E et al.Nephrology, dialysis, transplantation (Print). 2009, Vol 24, Num 10, pp 3168-3174, issn 0931-0509, 7 p.Article

Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. CommentaryBLOCK, G. A; RAGGI, P; BELLASI, A et al.Kidney international. 2007, Vol 71, Num 5, issn 0085-2538, 376-379, 438-441 [8 p.]Article